188 related articles for article (PubMed ID: 27213797)
1. [Significance of laser confocal tomography in diagnosis and monitoring of keratoconjunctivitis sicca].
Safonova TN; Gladkova ОV; Boev VI
Vestn Oftalmol; 2016; 132(2):47-54. PubMed ID: 27213797
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy].
Safonova TN; Gladkova OV; Boev VI; Fedorov AA
Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424
[TBL] [Abstract][Full Text] [Related]
3. [New approaches to the treatment of keratoconjunctivitis sicca].
Safonova TN; Gladkova OV; Novikov IA; Boev VI; Fedorov AA
Vestn Oftalmol; 2017; 133(2):75-81. PubMed ID: 28524144
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of Langerhans Cells in the Central Cornea as Tool for Monitoring Inflammatory Changes in Patients with Keratoconjunctivitis sicca under Topical Therapy with Cyclosporine A 0.05% Eye Drops].
Schneider E; Paulsen F; Jacobi C
Klin Monbl Augenheilkd; 2020 May; 237(5):669-674. PubMed ID: 32434251
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
Kaswan RL; Salisbury MA; Ward DA
Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen's syndrome].
Safonova TN; Gladkova OV; Boev VI
Vestn Oftalmol; 2019; 135(1):59-66. PubMed ID: 30830076
[TBL] [Abstract][Full Text] [Related]
8. [Topical cyclosporine for the treatment of ocular surface changes in contact lens wearers].
Egorova GB; Mitichkina TS; Fedorov AA; Shamsudinova AR
Vestn Oftalmol; 2015; 131(1):36-42. PubMed ID: 25872385
[TBL] [Abstract][Full Text] [Related]
9. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I; Szadkowski M
Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
[TBL] [Abstract][Full Text] [Related]
10. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.
Malhotra R; Devries DK; Luchs J; Kabat A; Schechter BA; Shen Lee B; Shettle L; Smyth-Medina R; Ogundele A; Darby C; Bacharach J; Karpecki P
Cornea; 2019 Oct; 38(10):1259-1265. PubMed ID: 31306284
[TBL] [Abstract][Full Text] [Related]
11. Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes.
Xiao W; Huang P
Arq Bras Oftalmol; 2022; 87(2):0539. PubMed ID: 36169441
[TBL] [Abstract][Full Text] [Related]
12. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca].
Schrell C; Cursiefen C; Kruse F; Jacobi C
Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827
[TBL] [Abstract][Full Text] [Related]
13. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
[TBL] [Abstract][Full Text] [Related]
14. The utility of an artificial substitute to improve corneal sensitivity in glaucomatous patients on chronic therapy with prostaglandin analogs.
Vagge A; Bonino M; Rolando M; Macrì A; Traverso CE; Iester M
J Ocul Pharmacol Ther; 2015 Jun; 31(5):286-90. PubMed ID: 25974240
[TBL] [Abstract][Full Text] [Related]
15. Color discrimination in patients with keratoconjunctivitis sicca before and after artificial tear application.
Rieger G
Wien Klin Wochenschr; 1998 Apr; 110(8):296-7. PubMed ID: 9615962
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tear film osmolarity using the TearLab
Sebbag L; Park SA; Kass PH; Maggs DJ; Attar M; Murphy CJ
Vet Ophthalmol; 2017 Jul; 20(4):357-364. PubMed ID: 27761982
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery.
Hamada S; Moore TC; Moore JE; Al-Dreihi MG; Anbari A; Shah S
Cont Lens Anterior Eye; 2016 Feb; 39(1):15-9. PubMed ID: 26275686
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic power of the tests for tear gland related keratoconjunctivitis sicca.
Klaassen-Broekema N; Mackor AJ; van Bijsterveld OP
Neth J Med; 1992 Apr; 40(3-4):113-6. PubMed ID: 1603200
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
